Correlation Between Editas Medicine and TG Therapeutics
Can any of the company-specific risk be diversified away by investing in both Editas Medicine and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Editas Medicine and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Editas Medicine and TG Therapeutics, you can compare the effects of market volatilities on Editas Medicine and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Editas Medicine with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Editas Medicine and TG Therapeutics.
Diversification Opportunities for Editas Medicine and TG Therapeutics
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Editas and TGTX is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Editas Medicine and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Editas Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Editas Medicine are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Editas Medicine i.e., Editas Medicine and TG Therapeutics go up and down completely randomly.
Pair Corralation between Editas Medicine and TG Therapeutics
Given the investment horizon of 90 days Editas Medicine is expected to under-perform the TG Therapeutics. In addition to that, Editas Medicine is 1.29 times more volatile than TG Therapeutics. It trades about -0.15 of its total potential returns per unit of risk. TG Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest 2,261 in TG Therapeutics on November 2, 2024 and sell it today you would earn a total of 1,075 from holding TG Therapeutics or generate 47.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Editas Medicine vs. TG Therapeutics
Performance |
| Timeline |
| Editas Medicine |
| TG Therapeutics |
Editas Medicine and TG Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Editas Medicine and TG Therapeutics
The main advantage of trading using opposite Editas Medicine and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Editas Medicine position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.| Editas Medicine vs. Beam Therapeutics | Editas Medicine vs. Crispr Therapeutics AG | Editas Medicine vs. Caribou Biosciences | Editas Medicine vs. Verve Therapeutics |
| TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |